Apr 19, 2024

Featuring perspectives from Dr Andrew H Ko and Dr Eileen M O’Reilly, including the following topics.

• Selection and Sequencing of Therapy for Patients with Metastatic Pancreatic Adenocarcinoma (PAD) — Dr Ko (0:00)
• Biomarker-Based Strategies for Metastatic PAD; Novel Investigational Approaches — Dr O’Reilly...

Apr 19, 2024

Featuring perspectives from Dr Kristen K Ciombor and Dr John Strickler, including the following topics.

• Select Biomarker-Directed Approaches for Colorectal Cancer (CRC) — Dr Ciombor (0:00)
• HER2-Targeted Approaches for Metastatic CRC (mCRC); Other Available and Emerging Therapeutic Strategies — Dr Strickler...

Apr 19, 2024

Featuring perspectives from Dr Ghassan Abou-Alfa and Dr Richard S Finn, including the following topics.

• Introduction (0:00)
• Hepatocellular Carcinoma (HCC) — Dr Abou-Alfa (8:30)
• Biliary Tract Cancers (BTCs) — Dr Finn (33:16)

CME information and select...

Apr 19, 2024

Featuring perspectives from Dr Yelena Y Janjigian and Dr Samuel J Klempner, including the following topics.

• Current and Potential Role of Immune Checkpoint Inhibitors in the Treatment of Gastroesophageal Cancers — Dr Klempner (0:00)
• Other Available and Emerging Therapeutic Approaches — Dr Janjigian (31:42)

CME...

Apr 19, 2024

Featuring perspectives from Dr Natalie S Callander and Dr Paul G Richardson, including the following topics.

• Introduction (0:00)
• Chimeric Antigen Receptor T-Cell Therapy, Bispecific Antibodies and Antibody-Drug Conjugates in Multiple Myeloma (MM) — Dr Callander (8:25)
• Integration of Other Novel Therapies into...